期刊
FRONTIERS IN IMMUNOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.532684
关键词
humanized mice; NK cell; Fc gamma R; ADCC; mouse innate immunity
类别
资金
- Japan Agency for Medical Research and Development [18H02368, 16K18405]
- Grants-in-Aid for Scientific Research [16K18405, 18H02368] Funding Source: KAKEN
We generated an NOD/Shi-scid-IL2R gamma(null) (NOG) mouse deficient for the Fcer1g and Fcgr2b genes (NOG-Fc gamma R-/- mice), in which monocytes/macrophages do not express activating (Fc gamma RI, III, and IV) or inhibitory (Fc gamma RIIB) Fc gamma receptors. Antibody-dependent cellular cytotoxicity (ADCC) by innate immune cells was strongly reduced in this strain. Thus, while the growth of xenogeneic human tumors engrafted in conventional NOG mice was suppressed by innate cells upon specific antibody treatment, such growth inhibition was abrogated in NOG-Fc gamma R-/- mice. Using this novel strain, we further produced NOG-Fc gamma R-/--mice expressing human IL-15 (NOG-Fc gamma R-/--hIL-15 Tg). The mice inherited unique features from each strain, i.e., the long-term sustenance of human natural killer (NK) cells, and the elimination of mouse innate cell-mediated ADCC. As a result, segregation of human NK cell-mediated ADCC from mouse cell-mediated ADCC was possible in the NOG-Fc gamma R-/--hIL-15 Tg mice. Our results suggest that NOG-Fc gamma R-/--hIL-15 Tg mice are useful for validating the in vivo function of antibody drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据